Jacobs Levy Equity Management, Inc Verastem, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.39 - $0.71 $99,095 - $180,403	254,090 Added 86.92%	546,422 $229,000
Q4 2022 Feb 14, 2023	SELL	$0.33 - $10.44 $28,509 - $901,932	-86,392 Reduced 22.81%	292,332 $116,000
Q3 2022 Nov 15, 2022	BUY	$0.92 - $11.16 $348,426 - $4.23 Million	378,724 New	378,724 $322,000
Q1 2022 May 16, 2022	SELL	$1.06 - $2.1 $208,903 - $413,865	-197,079 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.05 - $3.2 $151,749 - $236,876	-74,024 Reduced 27.3%	197,079 $404,000
Q2 2021 Aug 16, 2021	SELL	$2.57 - $4.85 $1.69 Million - $3.18 Million	-656,004 Reduced 70.76%	271,103 $1.1 Million
Q1 2021 May 17, 2021	BUY	$1.9 - $2.82 $101,625 - $150,833	53,487 Added 6.12%	927,107 $2.29 Million
Q4 2020 Feb 16, 2021	BUY	$1.15 - $2.4 $591,807 - $1.24 Million	514,615 Added 143.34%	873,620 $1.86 Million
Q3 2020 Nov 16, 2020	BUY	$1.11 - $1.68 $370,747 - $561,131	334,007 Added 1336.13%	359,005 $434,000
Q2 2020 Aug 17, 2020	BUY	$1.69 - $4.2 $42,246 - $104,991	24,998 New	24,998 $43,000
Q1 2019 May 14, 2019	SELL	$2.79 - $4.09 $47,988 - $70,348	-17,200 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$3.23 - $7.01 $151,910 - $329,687	-47,031 Reduced 73.22%	17,200 $58,000
Q3 2018 Nov 14, 2018	SELL	$6.86 - $9.97 $650,732 - $945,744	-94,859 Reduced 59.63%	64,231 $466,000
Q2 2018 Aug 14, 2018	BUY	$2.88 - $8.67 $4,320 - $13,005	1,500 Added 0.95%	159,090 $1.1 Million
Q1 2018 May 15, 2018	BUY	$2.92 - $3.81 $28,616 - $37,338	9,800 Added 6.63%	157,590 $470,000
Q4 2017 Feb 13, 2018	SELL	$2.99 - $4.85 $37,674 - $61,109	-12,600 Reduced 7.86%	147,790 $454,000
Q3 2017 Nov 14, 2017	SELL	$3.01 - $5.41 $189,329 - $340,289	-62,900 Reduced 28.17%	160,390 $754,000
Q2 2017 Nov 09, 2017	BUY	N/A	223,290	223,290 $487,000

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$942,750
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$201,120
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$83,800
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$12,507
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$4,500
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $880M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account